280 related articles for article (PubMed ID: 25083344)
41. Impaired RNA Binding Does Not Prevent Histone Modification Changes in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Son E; Segal R; Mathew S; Yousuf H; Torrente MP
MicroPubl Biol; 2023; 2023():. PubMed ID: 37746061
[TBL] [Abstract][Full Text] [Related]
42. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
Yamaguchi A; Takanashi K
Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
[TBL] [Abstract][Full Text] [Related]
43. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
[TBL] [Abstract][Full Text] [Related]
44. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia.
Yan J; Deng HX; Siddique N; Fecto F; Chen W; Yang Y; Liu E; Donkervoort S; Zheng JG; Shi Y; Ahmeti KB; Brooks B; Engel WK; Siddique T
Neurology; 2010 Aug; 75(9):807-14. PubMed ID: 20668259
[TBL] [Abstract][Full Text] [Related]
45. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.
Kamelgarn M; Chen J; Kuang L; Arenas A; Zhai J; Zhu H; Gal J
Biochim Biophys Acta; 2016 Oct; 1862(10):2004-14. PubMed ID: 27460707
[TBL] [Abstract][Full Text] [Related]
46. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
[TBL] [Abstract][Full Text] [Related]
47. DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis.
Konopka A; Atkin JD
Front Aging Neurosci; 2022; 14():786420. PubMed ID: 35572138
[TBL] [Abstract][Full Text] [Related]
48. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Haukedal H; Freude K
J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
[TBL] [Abstract][Full Text] [Related]
49. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
50. Super-Resolution Microscopy Reveals Presynaptic Localization of the ALS/FTD Related Protein FUS in Hippocampal Neurons.
Schoen M; Reichel JM; Demestre M; Putz S; Deshpande D; Proepper C; Liebau S; Schmeisser MJ; Ludolph AC; Michaelis J; Boeckers TM
Front Cell Neurosci; 2015; 9():496. PubMed ID: 26834559
[TBL] [Abstract][Full Text] [Related]
51. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.
Arenas A; Chen J; Kuang L; Barnett KR; Kasarskis EJ; Gal J; Zhu H
Hum Mol Genet; 2020 Sep; 29(16):2684-2697. PubMed ID: 32691043
[TBL] [Abstract][Full Text] [Related]
52. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for
Tischbein M; Baron DM; Lin YC; Gall KV; Landers JE; Fallini C; Bosco DA
J Biol Chem; 2019 Jun; 294(26):10194-10210. PubMed ID: 31092554
[TBL] [Abstract][Full Text] [Related]
53. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
54. Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.
Pham J; Keon M; Brennan S; Saksena N
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422969
[TBL] [Abstract][Full Text] [Related]
55. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.
Sun S; Ling SC; Qiu J; Albuquerque CP; Zhou Y; Tokunaga S; Li H; Qiu H; Bui A; Yeo GW; Huang EJ; Eggan K; Zhou H; Fu XD; Lagier-Tourenne C; Cleveland DW
Nat Commun; 2015 Jan; 6():6171. PubMed ID: 25625564
[TBL] [Abstract][Full Text] [Related]
56. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.
Kim SH; Shanware NP; Bowler MJ; Tibbetts RS
J Biol Chem; 2010 Oct; 285(44):34097-105. PubMed ID: 20720006
[TBL] [Abstract][Full Text] [Related]
57. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.
Alexander EJ; Ghanbari Niaki A; Zhang T; Sarkar J; Liu Y; Nirujogi RS; Pandey A; Myong S; Wang J
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11485-E11494. PubMed ID: 30442662
[TBL] [Abstract][Full Text] [Related]
58. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis.
Ling SC; Dastidar SG; Tokunaga S; Ho WY; Lim K; Ilieva H; Parone PA; Tyan SH; Tse TM; Chang JC; Platoshyn O; Bui NB; Bui A; Vetto A; Sun S; McAlonis-Downes M; Han JS; Swing D; Kapeli K; Yeo GW; Tessarollo L; Marsala M; Shaw CE; Tucker-Kellogg G; La Spada AR; Lagier-Tourenne C; Da Cruz S; Cleveland DW
Elife; 2019 Feb; 8():. PubMed ID: 30747709
[TBL] [Abstract][Full Text] [Related]
59. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
60. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
